News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
281,244 Results
Type
Article (17553)
Company Profile (39)
Press Release (263650)
Multimedia
Podcasts (24)
Webinars (5)
Section
Business (81658)
Career Advice (583)
Deals (14437)
Drug Delivery (34)
Drug Development (34311)
Employer Resources (40)
FDA (6228)
Job Trends (6281)
News (135463)
Policy (10309)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (1)
2027 Genetown Standard (2)
2027 Pharm Country Standard (2)
Academia (769)
Accelerated approval (22)
Adcomms (6)
Allergies (83)
Alliances (14502)
ALS (94)
Alzheimer's disease (688)
Antibody-drug conjugate (ADC) (226)
Approvals (6609)
Artificial intelligence (309)
Autoimmune disease (147)
Automation (24)
Bankruptcy (116)
Best Places to Work (4791)
BIOSECURE Act (2)
Biosimilars (119)
Biotechnology (24)
Bladder cancer (134)
Brain cancer (41)
Breast cancer (459)
Cancer (3196)
Cardiovascular disease (277)
Career advice (482)
Career pathing (8)
CAR-T (140)
CDC (9)
Celiac Disease (2)
Cell therapy (419)
Cervical cancer (27)
Clinical research (32066)
Collaboration (1027)
Company closure (3)
Compensation (644)
Complete response letters (26)
COVID-19 (951)
CRISPR (56)
C-suite (501)
Cystic fibrosis (73)
Data (4534)
Decentralized trials (2)
Denatured (5)
Depression (72)
Dermatology (47)
Diabetes (263)
Diagnostics (2479)
Digital health (24)
Diversity (3)
Diversity, equity & inclusion (11)
Drug discovery (154)
Drug pricing (77)
Drug shortages (10)
Duchenne muscular dystrophy (141)
Earnings (52485)
Editorial (20)
Employer branding (7)
Employer resources (35)
Events (46590)
Executive appointments (553)
FDA (8262)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (9)
Frontotemporal dementia (17)
Funding (858)
Gene editing (116)
Generative AI (20)
Gene therapy (333)
GLP-1 (538)
Government (1408)
Grass and pollen (5)
Guidances (359)
Healthcare (6704)
HIV (51)
Huntington's disease (23)
IgA nephropathy (59)
Immunology and inflammation (132)
Immuno-oncology (44)
Indications (91)
Infectious disease (1115)
Inflammatory bowel disease (97)
Inflation Reduction Act (9)
Influenza (61)
Intellectual property (106)
Interviews (112)
IPO (8040)
IRA (16)
Job creations (1763)
Job search strategy (411)
JPM (27)
Kidney cancer (10)
Labor market (40)
Layoffs (198)
Leadership (6)
Legal (2184)
Liver cancer (49)
Longevity (8)
Lung cancer (473)
Lymphoma (254)
Machine learning (29)
Management (12)
Manufacturing (419)
MASH (98)
Medical device (4969)
Medtech (5016)
Mergers & acquisitions (7057)
Metabolic disorders (693)
mRNA (63)
Multiple sclerosis (106)
NASH (10)
Neurodegenerative disease (200)
Neuropsychiatric disorders (54)
Neuroscience (1445)
Neurotech (1)
NextGen: Class of 2026 (2377)
Non-profit (1601)
Now hiring (16)
Obesity (310)
Opinion (81)
Ovarian cancer (108)
Pain (105)
Pancreatic cancer (127)
Parkinson's disease (175)
Partnered (12)
Patents (192)
Patient recruitment (299)
Peanut (25)
People (16917)
Pharmaceutical (9)
Pharmacy benefit managers (10)
Phase 1 (8853)
Phase 2 (14048)
Phase 3 (11928)
Pipeline (5087)
Policy (74)
Postmarket research (1072)
Preclinical (3024)
Press Release (44)
Prostate cancer (177)
Psychedelics (12)
Radiopharmaceuticals (115)
Rare diseases (529)
Real estate (2143)
Recruiting (14)
Regulatory (9028)
Reports (23)
Research institute (715)
Resumes & cover letters (117)
Rett syndrome (34)
RNA editing (9)
RSV (50)
Schizophrenia (90)
Series A (125)
Series B (105)
Service/supplier (5)
Sickle cell disease (52)
Special edition (11)
Spinal muscular atrophy (78)
Sponsored (15)
Startups (1251)
Stomach cancer (3)
Supply chain (54)
Tariffs (36)
The Weekly (18)
Vaccines (424)
Venture capital (40)
Weight loss (231)
Women's health (50)
Worklife (3)
Date
Today (82)
Last 7 days (464)
Last 30 days (1464)
Last 365 days (16560)
2026 (5645)
2025 (16821)
2024 (15104)
2023 (15017)
2022 (18874)
2021 (20132)
2020 (17969)
2019 (15531)
2018 (11806)
2017 (10742)
2016 (11549)
2015 (44338)
2014 (19413)
2013 (5930)
2012 (6496)
2011 (7322)
2010 (6288)
Location
Africa (374)
Alabama (29)
Alaska (3)
Arizona (101)
Arkansas (4)
Asia (17102)
Australia (2754)
California (7100)
Canada (1761)
China (620)
Colorado (291)
Connecticut (347)
Delaware (271)
Europe (41724)
Florida (839)
Georgia (182)
Hawaii (3)
Idaho (21)
Illinois (592)
India (49)
Indiana (352)
Iowa (11)
Japan (352)
Kansas (46)
Kentucky (19)
Louisiana (26)
Maine (38)
Maryland (721)
Massachusetts (5112)
Michigan (209)
Minnesota (303)
Mississippi (4)
Missouri (100)
Montana (11)
Nebraska (6)
Nevada (85)
New Hampshire (32)
New Jersey (2085)
New Mexico (6)
New York (1697)
North Carolina (761)
North Dakota (3)
Northern California (3569)
Ohio (178)
Oklahoma (7)
Oregon (15)
Pennsylvania (1158)
Puerto Rico (7)
Rhode Island (11)
South America (473)
South Carolina (18)
Southern California (2757)
Tennessee (117)
Texas (1119)
United States (24196)
Utah (184)
Virginia (150)
Washington D.C. (32)
Washington State (562)
West Virginia (3)
Wisconsin (104)
281,244 Results for "15".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Xenon to Present at Upcoming Investor Conferences - April 15, 2026
April 15, 2026
·
1 min read
Press Releases
Milestone Scientific Inc. Completes $2.15 Million Private Placement
April 21, 2026
·
4 min read
Mergers & acquisitions
UCB elevates epilepsy expertise with up to $1.15B Neurona takeover
The acquisition of Neurona will put UCB in both the epilepsy and cell therapy space, even as many of its fellow pharmas move away from the latter modality.
April 20, 2026
·
2 min read
·
Tristan Manalac
Press Releases
ImmunoForge to Accelerate CNS Drug Development with Innovative BBB Shuttle Platform ‘LMT15'
April 22, 2026
·
3 min read
Press Releases
Cerapedics Announces Supplier Agreement with Vizient for PearlMatrix® P-15 Peptide Enhanced Bone Graft
April 26, 2026
·
6 min read
Press Releases
PAVmed to Hold First Quarter 2026 Business Update Conference Call and Webcast on May 15, 2026
May 1, 2026
·
2 min read
Press Releases
AbbVie IBD Scholarship Program Marks 15 Years: Applications Open for 2026
April 2, 2026
·
4 min read
Collaboration
Kite Makes $1.5B+ Cell Therapy Pact With Pregene as Others Pull Back
With more than $1.5 billion on the line, Gilead looks to bolster its CAR T portfolio.
October 17, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Immusoft Awarded $15 Million in Funding from the California Institute for Regenerative Medicine
March 30, 2026
·
4 min read
Press Releases
Atrium Therapeutics Earns $15 Million Milestone Payment from Bristol Myers Squibb Under Global Cardiovascular Collaboration
April 23, 2026
·
7 min read
1 of 28,125
Next
